Lauren Orenstein, MD, FAAD
SESSIONS
S056 Hidradenitis Suppurativa/Acne Inversa (HS/AI): Current Medical and Surgical Management
Mar 30, 2026
•
1:00 PM - 4:00 PM
•
Four Seasons 3
DISCLOSURES
HS Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees); Novartis – Advisory Board(Fees), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Phrase Health – Stockholder(Stock); UCB Pharma – Advisory Board(Fees);